Current Report Filing (8-k)
August 11 2020 - 4:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2020
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as specified in its charter)
Delaware
|
|
1-14120
|
|
52-1611421
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
One Jake Brown Road, Old Bridge, New Jersey
|
|
08857
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code: (732) 679-4000
Not Applicable
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
☐
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $.001
|
|
BDR
|
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On August
6, 2020, Blonder Tongue Laboratories, Inc. (the "Company") expanded the size of its Board of Directors from ten to eleven
members and appointed Rick Briggs as a director to fill the vacancy. Mr. Briggs co-founded Stellar Private Cable, Inc. (doing
business as "SeniorTV") and served as its President until its sale to Sentrics Holdings, LLC ("Sentrics")
in November 2018. Following the sale to Sentrics, he continued to serve as President on a transition basis until January 2020,
also served as its Chief Marketing Officer and then served as a consultant to Sentrics from January 2020 until May 2020. He holds
a Bachelor of Science degree in Advertising from Kent State University.
Mr. Briggs
will serve as a director in Class I, with a term expiring at the Company's annual meeting of stockholders in 2023. Mr. Briggs'
board of directors committee assignments have not yet been determined. The Company's Board of Directors has determined that Mr.
Briggs meets the requirements for independence under applicable Securities and Exchange Commission and NYSE American rules and
standards. There are no arrangements or understandings pursuant to which Mr. Briggs was appointed as a director, and there are
no related party transactions between the Company and Mr. Briggs reportable under Item 404(a) of Regulation S-K. In connection
with his service as a director, Mr. Briggs will be entitled to the same compensation and benefits made available to the Company's
non-employee directors generally, pro-rated for the term of his service during calendar year 2020.
A copy
of the press release announcing the appointment of Mr. Briggs is attached hereto as Exhibit 99.1 and incorporated into this Item
5.02 by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
The following exhibit is filed herewith:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BLONDER TONGUE LABORATORIES, INC.
|
|
|
|
By:
|
/s/ Eric Skolnik
|
|
|
Eric Skolnik
Senior Vice President and Chief Financial Officer
|
Date:
August 11, 2020
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Sep 2023 to Sep 2024